Novo Nordisk A/S Sponsored ADR (NOVA)
FSX
34.20
+0.98 (+2.95%)
Real-time Data
06:00 AM
Day's Range
32.9434.23
52 wk Range
30.4554.80
Financial Statements - NOVA - Novo Nordisk A/S Sponsored ADR
Revenue
309.06B▲ 694.8%
Net Income
102.43B▲ 657.5%Net Margin 33.1%
EBITDA
150.65B▲ 712.8%
Free Cash Flow
28.98B▲ 210.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 309.06B | 38.88B | 31.13B | 23.72B | 18.87B | 17.01B |
| Cost of Goods | 58.78B | 5.96B | 4.79B | 3.81B | 3.17B | 2.80B |
| Gross Profit | 250.27B | 32.92B | 26.33B | 19.90B | 15.70B | 14.21B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 127.65B | 17.18B | 13.74B | 10.02B | 7.86B | 7.25B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 6.06B | -141.53M | 237.23M | -727.58M | 82.58M | -106.31M |
| Pre Tax Income | 130.54B | 17.03B | 14.02B | 9.25B | 7.92B | 7.12B |
| Income Tax | 28.10B | 3.50B | 2.81B | 1.81B | 1.51B | 1.47B |
| Net Income | 102.43B | 13.52B | 11.21B | 7.44B | 6.40B | 5.64B |
| EPS Basic | 23.06 | 22.67 | 18.67 | 12.26 | 10.395 | 9.025 |
| EPS Diluted | 23.03 | 22.63 | 18.62 | 12.22 | 10.37 | 9.005 |
| Basic Shares Outstanding | 4.44B | 596.37M | 4.48B | 4.53B | 4.59B | 4.66B |
| Diluted Shares Outstanding | 4.44B | 596.37M | 4.48B | 4.53B | 4.59B | 4.66B |
| Ebit | 134.74B | 17.25B | 14.10B | 9.30B | 7.95B | 7.17B |
| Ebitda | 150.65B | 18.53B | 15.13B | 10.99B | 8.68B | 8.07B |
| Net Income Continuous Operations | 102.43B | 13.52B | 11.21B | 7.44B | 6.40B | 5.64B |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
